Castleview Partners’s Idexx Laboratories IDXX Stock Holding History

Castleview Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$223K	Buy	423 +3	+0.7%	+$1.68K	0.1%	197
2026 Q1	$236K	Sell	420 -85	-17%	-$54.5K	0.12%	176
2025 Q4	$342K	Buy	505 +4	+0.8%	+$2.72K	0.17%	125
2025 Q3	$320K	Hold	501	–	–	0.17%	123
2025 Q2	$269K	Buy	+501	New	+$240K	0.17%	140
2024 Q2	–	Sell	-69	Closed	-$37.3K	–	961
2024 Q1	$37.3K	Hold	69	–	–	0.02%	383
2023 Q4	$38.3K	Hold	69	–	–	0.03%	356
2023 Q3	$30.2K	Hold	69	–	–	0.03%	323
2023 Q2	$34.7K	Hold	69	–	–	0.03%	307
2023 Q1	$34.5K	Hold	69	–	–	0.03%	295
2022 Q4	$28.1K	Hold	69	–	–	0.03%	277
2022 Q3	$22K	Sell	69 -1,063	-94%	-$390K	0.02%	312
2022 Q2	$206K	Buy	1,132 +1,014	+859%	+$413K	0.16%	136
2022 Q1	$64K	Sell	118 -77,580	-100%	-$40.8M	0.04%	316
2021 Q4	$118	Buy	+77,698	New	+$48.8M	﹤0.01%	765
2021 Q2	$75K	Buy	+118	New	+$65.2K	0.03%	338

Other funds holding IDXX

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

MIM

Manitou Investment Management Toronto, Ontario, Canada $538M AUM 13.79% 1-Year Est. Return

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

HCM

Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Castleview Partners's IDXX Position: Q2 2026 in Review

Castleview Partners increased its Idexx Laboratories (IDXX) stake by 0.71% in Q2 2026, buying an estimated $1.68K and bringing the position to 423 shares worth $223K. The position accounts for 0.1% of the portfolio, ranked #197.

Castleview Partners first reported a position in IDXX in Q2 2021 and has held it in 16 quarters since. The position peaked at $342K in Q4 2025. 205 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Castleview Partners held 423 shares of Idexx Laboratories worth $223K as of Q2 2026.
Castleview Partners bought 3 Idexx Laboratories shares in Q2 2026, an estimated $1.68K.
Idexx Laboratories made up 0.1% of Castleview Partners's portfolio in Q2 2026, its #197 holding.
Castleview Partners first reported a position in Idexx Laboratories in Q2 2021 and has held it in 16 quarters since.
Castleview Partners's Idexx Laboratories position peaked at $342K in Q4 2025.
205 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.